Statins as adjunct therapy in COPD: is it time to target innate immunity and cardiovascular risk?

Robert P. Young, Raewyn J. Scott

Source: Eur Respir J, 58 (1) 2100342; 10.1183/13993003.00342-2021
Journal Issue: July
Disease area: Airway diseases

Congress or journal article abstractFull text journal articlePDF journal article, handout or slides

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Robert P. Young, Raewyn J. Scott. Statins as adjunct therapy in COPD: is it time to target innate immunity and cardiovascular risk?. Eur Respir J, 58 (1) 2100342; 10.1183/13993003.00342-2021

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you: